β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines

Laboratory Investigation

Volumn 93, Issue 3, 2013, Pages 279-290

  Moretti, Silvia ^a   Massi, Daniela ^a   Farini, Valentina ^a   Baroni, Gianna ^a   Parri, Matteo ^a   Innocenti, Stefania ^b   Cecchi, Roberto ^b   Chiarugi, Paola ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b PISTOIA HOSPITAL   (Italy)

Author keywords

adrenoceptor; immunohistochemistry; melanoma; melanoma progression; norepinephrine epinephrine

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR; ILOMASTAT; INTERLEUKIN 6; INTERLEUKIN 8; METALLOPROTEINASE; NORADRENALIN; PROPRANOLOL; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CELL MOTILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DYSPLASTIC NEVUS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA CELL; METASTATIC MELANOMA; OUTCOME ASSESSMENT; PLEIOTROPY; PRIORITY JOURNAL; UPREGULATION;

ADULT; BLOTTING, WESTERN; CELL LINE, TUMOR; CYTOKINES; DNA PRIMERS; EPINEPHRINE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MELANOMA; METALLOPROTEASES; MIDDLE AGED; NOREPINEPHRINE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, BETA; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874595409     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.175     Document Type: Article

References (33)

1. MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol 2009;20(Suppl 6):vi1-vi7
2. Atallah E, Flaherty L. Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 2005;6:185-193
3. Drell 4th TL, Joseph J, Lang K, et al. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 2003;80:63-70
4. Masur K, Niggemann B, Zanker KS, et al. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by betablockers. Cancer Res 2001;61:2866-2869
5. Palm D, Lang K, Niggemann B, et al. The norepinephrinedriven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer 2006;118:2744-2749
6. Sood AK, Bhatty R, Kamat AA, et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res 2006;12:369-375
7. Yang EV, Sood AK, Chen M, et al. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 2006;66:10357-10364
8. Shang ZJ, Liu K, Liang de F. Expression of beta2-adrenergic receptor in oral squamous cell carcinoma. J Oral Pathol Med 2009;38: 371-376
9. Entschladen F, Lang K, Drell TL, et al. Neurotransmitters are regulators for the migration of tumor cells and leukocytes. Cancer Immunol Immunother 2002;51:467-482
10. Voss MJ, Entschladen F. Tumor interactions with soluble factors and the nervous system. Cell Commun Signal 2010;8:21
11. Glasner A, Avraham R, Rosenne E, et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol 2010;184: 2449-2457
12. Powe DG, Entschladen F. Targeted therapies: Using b-blockers to inhibit breast cancer progression. Nat Rev Clin Oncol 2011;8: 511-512
13. De Giorgi V, Grazzini M, Gandini S, et al. Treatment with b-blockers and reduced disease progression in patients with thick melanoma. Arch Intern Med 2011;171:779-781
14. Lemeshow S, S-rensen HT, Phillips G, et al. b-Blockers and survival among Danish patients with malignant melanoma: A populationbased cohort study. Cancer Epidemiol Biomarkers Prev 2011;20: 2273-2279
15. Yang EV, Kim SJ, Donovan EL, et al. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression. Brain Behav Immun 2009;23:267-275
16. Steinkraus V, Mak JC, Pichlmeier U, et al. Autoradiographic mapping of beta-adrenoceptors in human skin. Arch Dermatol Res 1996;288: 549-553
17. Sivamani RK, Lam ST, Isseroff RR. Beta adrenergic receptors in keratinocytes. Dermatol Clin 2007;25:643-653
18. Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 2011;10:417-427
19. Ara T, Declerck YA. Interleukin-6 in bone metastasis and cancer progression. Eur J Cancer 2010;46:1223-1231
20. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008;14:6735-6741
21. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392-401
22. Tomasek JJ, Gabbiani G, Hinz B, et al. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002;3:349-363
23. Pak Y, Pham N, Rotin D. Direct binding of the b1 adrenergic receptor to the cyclic AMP-dependent guanine nucleotide exchange factor CNrasGEF leads to Ras activation. Mol Cell Biol 2002;22: 7942-7952
24. Meier F, Busch S, Lasithiotakis K, et al. Combined targeting of MAPK and Akt signalling pathways is a promising strategy for melanoma treatment. Br J Dermatol 2007;156:1204-1213
25. Hofmann UB, Westphal JR, Van Muijen GN, et al. Matrix metalloproteinases in human melanoma. J Invest Dermatol 2000; 115:337-344
26. Parri M, Taddei ML, Bianchini F, et al. EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. Cancer Res 2009;69:2072-2081
27. Singh RK, Varney ML. IL-8 expression in malignant melanoma: Implications in growth and metastasis. Histol Histopathol 2000;15:843-849
28. Moretti S, Pinzi C, Spallanzani A, et al. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int J Cancer 1999;84:160-168
29. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003;200:429-447
30. Dvorak HF, Weaver VM, Tlsty TD, et al. Tumor microenvironment and progression. J Surg Oncol 2011;103:468-474
31. Dong J, Grunstein J, Tejada M, et al. VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J 2004;23:2800-2810
32. Azpiroz A, De Miguel Z, Fano E, et al. Relations between different coping strategies for social stress, tumor development and neuroendocrine and immune activity in male mice. Brain Behav Immun 2008;22:690-698
33. Vegas O, Fano E, Brain PF, et al. Social stress, coping strategies and tumor development in male mice: Behavioral, neuroendocrine and immunological implications. Psychoneuroendocrinology 2006;31:69-79